Next Quarterly Earnings
Tuesday, November 3, 2026
Expected
Soleno Therapeutics
Soleno Therapeutics is a U.S.-based biopharmaceutical company specializing in the development of innovative therapies for rare genetic disorders. The company focuses on researching novel treatment approaches, particularly for Prader-Willi syndrome, to enhance the standard of care for patients.
Frequently asked questions
How often has Soleno Therapeutics beaten expectations?
Soleno Therapeutics has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
How do I add the Soleno Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
3/4
Quarters above estimates
75%
Beat rate
+2%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Soleno Therapeutics
Country
🇺🇸
More Financial Information